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1 We have characterized an adenosine receptor subtype present in human airway epithelial cells by
measuring the changes in the intracellular levels of adenosine 3':5'-cyclic monophosphate (cyclic AMP)
and the rate of transepithelial Cl- secretion.
2 Primary cultures of human nasal epithelium obtained from excised surgical airway epithelial tissues
and the cell lines BEAS39 and CF/T43 derived from human airway epithelium were grown on plastic
dishes and labelled with [3H]-adenine for measurement of intracellular cyclic AMP accumulation.
Primary cultures were loaded with the calcium indicator fura-2 to measure [Ca2+]i and studied as
polarized, ion transporting epithelia on collagen matrix supports for measurement of C1- secretion.
3 Adenosine analogues stimulated cyclic AMP accumulation with a rank order of potency characteris-
tic of an A2-receptor: 5-N-ethyl-carboxamidoadenosine (NECA)> adenosine> R-phenylisopropyladeno-
sine (R-PIA), 6-N-cyclopentyladenosine (CPA)> S-PIA. NECA increased cyclic AMP accumulation in
normal and cystic fibrosis (CF) primary cells as well as in the CF/T43 and BEAS39 cell lines with K0.5
values ranging from 0.3 to 3 LM. Preincubation with NECA resulted in the homologous desensitization
of airway epithelial cells. The effect of NECA was specifically inhibited by the adenosine receptor
antagonist, aminophylline, in a competitive manner.
4 The Al-adenosine receptor agonists CPA and R-PIA did not inhibit isoprenaline-stimulated cyclic
AMP accumulation in CF/T43 cells, and potentiating effects of the adenosine analogues were observed
on forskolin-stimulated cyclic AMP accumulation. Adenosine analogues did not cause significant
changes in intracellular Ca2+ ([Ca2+],) in airway epithelium.
5 Adenosine analogues, applied to either the serosal or mucosal side of the polarized amiloride
pretreated primary cultures, induced changes in I,, with a rank order of potency of agonists similar to
that observed for stimulation of cyclic AMP accumulation. Intracellular microelectrode studies indicated
that the locus of action was the apical membrane Cl- conductance. Adenosine failed to stimulate C1-
secretion in CF airway epithelium.
6 These results provide evidence for the existence of an A2-adenosine receptor that modulates intracel-
lular levels of cyclic AMP in human airway epithelium. Activation of this receptor might lead to
stimulation of Cl- secretion in amiloride pretreated normal but not CF cells.
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Introduction
Extracellular adenosine and adenine nucleotides modulate a
variety of physiological processes by interacting with specific
membrane bound receptors, termed PI-purinoceptors for
those activated by adenosine and P2-purinoceptors for recep-
tors activated by adenosine 5'-triphosphate (ATP) (Burn-
stock, 1978). The adenosine receptors have been subclassified
into two major subtypes, Al and A2, according to their
ability to increase (A2) or decrease (Al) adenylate cyclase
activity and the relative potencies of a series of adenosine
analogues (Van Calker et al., 1979; Londos et al., 1980;
Daly, 1982; Stone, 1991). The A2-receptor exhibits a potency
order of 5-N-ethyl-carboxamidoadenosine (NECA)>adeno-
sine> R-phenylisopropyladenosine (R-PIA), N-6-cyclopentyl-
adenosine (CPA) > S-PIA, while the order of potency at the
Al-receptor is R-PIA, CPA> adenosine>NECA> S-PIA.
Activation of both classes of adenosine receptors is com-
petitively antagonized by methylxanthines (Sattin & Rall,
1970; Fredholm, 1980; Daly et al., 1983; Parsons & Stiles,
1985).
Recent findings suggest that adenosine receptors may regu-
late second messenger systems in addition to adenylate
cyclase. For example, an adenosine-mediated increase of
intracellular Ca2+ ([Ca2+],) in rat mast cells has been reported
to be secondary to activation of phosphoinositide turnover
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(Ali et al., 1990). Adenosine receptors may also regulate
cardiac K + conductance by a mechanism not involving
adenosine 3':5'-cyclic monophosphate (cyclic AMP) (Bohm et
al., 1986). Ribeiro & Sebastiao (1986) have proposed that a
third type of adenosine receptor, termed A3, is coupled to
calcium channels and exhibits an agonist potency order not
consistent with that of the Ar- or A2-receptor subtypes.
In epithelia, adenosine receptor activation is functionally
coupled to regulation of ion transport rates. Adenosine regu-
lates the rate of chloride ion secretion in a variety of
epithelial tissues including frog cornea (Spinowitz & Zadun-
aisky, 1979), rabbit ileum (Dobbins et al., 1984), canine
trachea (Pratt et al., 1986), rabbit kidney cortical collecting
duct (CCD) (Schwiebert et al., 1990) and T84 human colonic
epithelial cells (Barrett et al., 1989). In a number of these
target tissues the effect of adenosine on Cl- transport is
accompanied by elevation of cyclic AMP suggesting involve-
ment of an A2-adenosine receptor.
Cl- transport by airway epithelia is likely to play an
important role in modulating the volume and composition of
pulmonary secretions. A defective regulation of Cl- transport
by airway epithelia may be involved in lung diseases, e.g.
cystic fibrosis (CF) (Frizzell et al., 1986; Welsh & Liedtke,
1986; Boucher et al., 1988; Riordan et al., 1989; Rommens et
al., 1989). We previously observed that extracellular nucleo-
tides such as ATP and UTP stimulate Cl- secretion in both
normal and CF airway epithelial cells pretreated with ami-
loride (Mason et al., 1991). This effect was associated with an
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elevation of intracellular Ca2+ (Mason et al., 1991) and
inositol phosphates (Brown et al., 1991). The objective of the
present study was to determine the presence of adenosine
receptors on human airway epithelia and to establish whether
adenosine receptors modulate Cl- secretion in amiloride
pretreated human airway epithelia.
Methods
Cell culture
Cell lines derived from airway epithelium from a normal
subject (BEAS39, Reddel et al., 1988) and from a CF patient
(CF/T43, Jetten et al., 1989) by introduction of SV40T, were
grown to confluence in hormone supplemented serum-free
medium (KGM) on plastic tissue culture 12 well plates (Co-
star, Cambridge, MA, U.S.A.) Human nasal epithelium from
normal or cystic fibrosis subjects was obtained from freshly
excised nasal tissue by standard techniques (Wu et al., 1985).
Epithelial cells were harvested from these specimens and
cultured to confluence on plastic 12 well plates for cyclic
AMP studies, on non-fluorescent vitrogen coated glass cover-
slips for intracellular Ca2+ measurements, or on permeable
collagen matrix supports for bioelectric measurements. An
F12 based, serum-free medium supplemented with hydrocor-
tisone 5ngml[', insulin lOLgml', transferrin 5JAgml-',
endothelial cell growth substance 3.7 pg ml-', and 30 nM T3
(F12, 4.lX) was the culture medium for primary cells. In
previous studies using cholera toxin (CTX)-containing med-
ium, negligible Cl- secretory response to adenosine was
observed (Mason et al., 1991). For this reason, CTX was
omitted from the culture medium for these studies.
Measurement of cyclic AMP accumulation
Cyclic AMP accumulation was monitored essentially as des-
cribed previously (Hughes & Harden, 1986). Briefly, cells
were incubated for 3 h with 1 ml of HEPES-buffered (20 mM,
pH 7.5) Eagle's modified essential medium (EMEM) contain-
ing 2-3iCi ml-' of [3H]-adenine. The medium was aspirat-
ed, the cells were washed twice with 1 ml of HEPES-EMEM
and fresh aliquots of 1 ml HEPES-EMEM were added.
Except where indicated, papaverine 200 JM, was added
O min before incubation with agonists. The reactions were
carried out at 37°C and they were terminated at the indicated
times by aspiration of the medium followed by the immediate
addition of 1 ml 5% trichloroacetic acid containing 0.5 mM
cyclic AMP. [3H]-cyclic AMP was separated from [3H]-ATP
by sequential passage of the trichloroacetic acid extract over
Dowex and alumina columns as described previously (Harden
et al., 1982). Aliquots of the cyclic AMP fractions were
assayed spectrophotometrically at 259 nm to correct for
recovery of cyclic AMP. Experiments were carried out with
triplicate samples that differed less than 10% from the mean.
The results are expressed as the precentage conversion of
[3H]-ATP to [3H]-cyclic AMP. Except where indicated, the
cell cultures were supplemented with adenosine deaminase
2 u ml-' for 12 h before measurement of cyclic AMP
accumulation.
Measurement of intracellular calcium
Primary nasal epithelial cells grown to confluence on vitro-
gen-coated coverslips were loaded with a final concentration
of 3pJM Fura-2 acetomethylester (Fura-2/AM) at 37°C for
30min. [Ca2+]i was measured as described by Mason et al.
(1991) with a modular microspectrofluorimeter (SPEX Indus-
tries Inc., Edison, NJ, U.S.A.).
Bioelectric studies
Confluent monolayers of primary human nasal epithelium
were mounted in modified Ussing chambers (Knowles et al.,
1983; Boucher et al., 1988). The cultures were maintained at
37°C and continuously perfused with a standard Krebs
Ringer bicarbonate solution with amiloride (100 pM) added
to the apical bath to block transepithelial Na+ transport. The
current required to clamp the spontaneous transepithelial
potential difference (V,), the short circuit current (4), was
measured under voltage clamp (short circuit) conditions.
Changes in I4, (AI), transepithelial resistance (R.) and V,
were measured as described previously (Mason et al., 1991).
Intracellular microelectrode techniques for electrophysio-
logical measurement have been described in detail elsewhere
(Willumsen et al., 1989; Clarke et al., 1991). In brief, the
culture cups were inserted in a horizontally-oriented Ussing
chamber and perfused as indicated above. V, was continuous-
ly measured and constant current pulses (-40 AA cm-2, 1)
were passed across the tissue for measurement of trans-
epithelial resistance (R, = AV,/1). The equivalent short circuit
current (Iq) was calculated from Ohm's law. Cells were
impaled vertically across the apical membrane with conven-
tional microelectrodes backfilled with 3 mM KCI (tip resis-
tance -- 130 mQ). The apical membrane potential (Va) and Vt
were referenced to the apical bath and the basolateral memb-
rane potential (Vb = V,- Va) was referenced to the baso-
lateral bath. The fractional resistance of the apical membrane
(fRa) was calculated from the equation, fRa = Ra/(Ra +
Rb) = AVa/AVt where Ra and Rb are the resistance of the
apical and basolateral membranes, respectively, and AVa and
AV, are the changes in the voltage signals in response to I.
Chemicals and solutions
Forskolin, NECA, R-PIA, 2-methylthio-ATP, papaverine
and aminophylline were from Research Biochemicals Inc.
(Natick, MA, U.S.A.). Isoprenaline, cyclic AMP, CPA, 3-
isobutyl-l-methylxanthine (IBMX), adenosine deaminase,
ADP, grade I neutral alumina and all nucleosides were pur-
chased from Sigma (St. Louis, MO, U.S.A.). AG 50W-X4
Dowex resin was purchased from Bio-Rad Laboratories
(Richmond, CA, U.S.A.). UTP, ATP and other adenine
nucleotides were from Boehringer Mannheim Biochemicals
(Indianapolis, IN, U.S.A.). Fura-2/AM and Fura-2 penta-
potassium salt were purchased from Molecular Probes
(Eugene, OR, U.S.A.). [2,8-3H]-adenine was purchased from
Amersham Corp (Arlington Heights, IL, U.S.A.). Hormones
for culture medium were from Collaborative Research Inc
(Waltham, MA, U.S.A.). Keratinocyte growth medium
(KGM) was purchased from Clonetics (San Diego, CA,
U.S.A.). Eagle's modified essential medium and Ham's F-12
cell culture medium were purchased from Gibco (Grand
Island, NY, U.S.A.).
Results
Under resting conditions, there was no detectable accumula-
tion of [3H]-cyclic AMP from [3H]-ATP in [3H]-adenine pre-
labelled CF/T43 cells without or with cyclic nucleotide
phosphodiesterase (PDE) inhibitors (Table 1). Exposure of
the cells to isoprenaline or the adenosine analogue, NECA,
resulted in stimulation of [3H]-cyclic AMP accumulation
(Table 1). The methylxanthine PDE inhibitors such as IBMX
are known to antagonize competitively P,-purinoceptors
(Parsons & Stiles, 1985). In contrast, papaverine does not
interact with A,- or A2-adenosine receptors. As illustrated in
Table 1, 200 JAM papaverine potentiated cyclic AMP elevation
at concentrations of NECA that had no effect on cyclic AMP
accumulation in the presence of 200 JM IBMX. The response
to isoprenaline was similar, irrespective of whether IBMX or
papaverine was used as a PDE inhibitor (Table 1). Based on
these and other results, 200 JAM papaverine was routinely
included as a PDE inhibitor in all assays. The nature of the
effect of methylxanthines on the adenosine receptor response
is examined further below.
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Table 1 Effect of phosphodiesterase (PDE) inhibitors on
cyclic AMP accumulation in CF/T43 cells





Isoprenaline (10 JM) + IBMX
Isoprenaline (10 JM) + papaverine
NECA (1 gM)
NECA (1 JM) + IBMX
NECA (1 JM) + papaverine
NECA (100 AM)
NECA (100JM) + IBMX













this value is brought into question by the fact that the slope
of the line of the transformed data (- 1.7) differs significantly
from the value (- 1) expected for a competitive antagonist.
Lack of achievement of equilibrium conditions under the
necessary restricted conditions of this experiment seems
likely.
Forskolin, which directly activates adenylate cyclase
(Seamon & Daly, 1981), is also known to potentiate the
actions of receptors activating this enzyme through G,, e.g.
P-adrenoceptors and adenosine receptors (Seamon et al.,
1981; Daly et al., 1982). We examined the effect of forskolin
Cells were labelled and washed as described in Methods and
preincubated for 10 min with vehicle, 200 JAM isobutyl-
methylxanthine (IBMX), or 200 JM papaverine. The cells
were challenged for 5 min with the indicated concentration
of isoprenaline or 5-N-ethyl-carboxamidoadenosine (NECA).
The data are means ± s.d. from one experiment performed
in triplicate and are representative of 3 different experi-
ments.
The pharmacological characteristics of the adenosine
receptor involved in the elevation of cyclic AMP in CF/T43
cells was examined. Accumulation of cyclic AMP was stimu-
lated with an order of potency of NECA> adenosine>
CPA, R-PIA> S-PIA (Figure 1). Thymidine, cytidine,
uridine, guanidine or inosine did not stimulate cyclic AMP
accumulation at millimolar concentrations (data not shown).
These results suggest that an A2-adenosine receptor activates
adenylyl cyclase in CF/T43 cells.
The time course of accumulation of cyclic AMP in CF/T43
cells was compared in the presence of maximal concentra-
tions of NECA or isoprenaline. The initial rate of cyclic
AMP accumulation in the presence of NECA was approx-
imately one half of that observed for isoprenaline (Figure 2).
After a 3-4 min exposure of cells to NECA no further
increase in cyclic AMP occurred and addition of fresh NECA
did not induce further cyclic AMP formation. In contrast,
addition of isoprenaline to NECA-treated cells resulted in a
further increase in cyclic AMP formation with an initial rate
similar to that observed in cells treated with isoprenaline
alone (Figure 2). These results suggest that CF/T43 cells
underwent a rapid and receptor-specific desensitization to
NECA, as previously described for A2-receptors in other cells
(Kenimer & Nirenberg, 1981; Newman & Levitzki, 1983;
Ramkumar et al., 1991).
The theophylline analogue, aminophylline, has been shown
to block the effect of adenosine on A2-receptors (Hartzell,
1979). Preincubation of CF/T43 cells with aminophylline
resulted in a concentration-dependent reduction in NECA-
stimulated cyclic AMP accumulation (Figure 3). In contrast,
aminophylline had no effect on the action of isoprenaline
(Figure 3). The apparent potency of aminophylline for inhibi-
tion of the NECA response varied with the time of prein-
cubation with antagonist and with the length of drug
challenge (data not shown). Thus, concentration-effect curves
for NECA were generated in the presence of varying concen-
trations of aminophylline, under conditions in which amino-
phylline and NECA were added concurrently. Incubations
were for 2 min in order to minimize the contribution of
agonist-induced desensitization. The concentration-effect
curve for NECA was shifted to the right in a parallel fashion
by increasing concentrations of aminophylline (Figure 4).
These data suggest competitive inhibition of the NECA res-
ponse by aminophylline. The apparent inhibition constant for
aminophylline was estimated by Schild analysis (Arunlak-
shana & Schild, 1959). The calculated pA2 value was 4.8
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Figure 1 Effect of adenosine analogues on the accumulation of
cyclic AMP in CF/T43 cells. Cells were labelled and preincubated as
indicated in Methods and challenged for 2min with the indicated
concentrations of NECA (0), adenosine (@), CPA (0), R-PIA (A),
S-PIA (A), ADP (O), ATP (A) or UTP (*). Adenosine deaminase
was omitted from the incubations. The data are representative of
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Figure 2 Time-dependent effect of isoprenaline and NECA on the
accumulation of cyclic AMP in CF/T43 cells. Cells were labelled and
preincubated with 200 J1M papaverine as indicated in Methods. The
cells were challenged with 1O JM isoprenaline (0) or 100 JAM NECA
(0) for the indicated times or they were preincubated with 100AM
NECA for 5 min and further incubated for 3 and 5 min with 10 JM
isoprenaline (0) or 100IJM NECA (U). Results are the mean of
triplicate determinations. The data are representative of results from
three experiments. For abbreviations, see text.
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Figure 3 Effect of aminophylline on NECA and i,
lated accumulation of cyclic AMP in CF/T43 cel
preincubated for 10 min with the indicated concenl
phylline and challenged for 5 min with 10 gM isC
NECA (0). The results are plotted as the percenta
in the absence of aminophylline and are the n















III,,,,,HIM ,,,,,M. ,I,,, , ,,,,, ,
10-8 10-7 10-6 10-5 10-4
[NECA] M
Figure 4 Effect of aminophylline on the stimulati,
accumulation by NECA. CF/T43 cells were lal
cubated as indicated in the legend of Figure 2
incubated for 2 min with the indicated concentr
alone (0) or with the concurrent addition of 10 gr1
50 jaM (U), or 100 JiM (A) aminophylline. The resi
percentage conversion of [3H]-ATP to [3H]-cyclic )
mean of triplicate determinations. For abbreviati
on cyclic AMP accumulation in isoprenalin
stimulated CF/T43 cells. Addition of isopre
skolin to CF/T43 cells, resulted in cyclic AM
at levels 2-3 times larger than that expel
additivity between the two stimuli (not ;
results were obtained in CF/T43 cells stimi
skolin combined with NECA (Figure 5a) or
R-PIA or CPA (not shown). Incubation of
with 1 gAM NECA or higher resulted in max
tion of cyclic AMP, and a similar level
accumulation was produced by 10tiM forsl
the addition of forskolin in combination with
in marked potentiation of their respective el
potentiated cyclic AMP elevation at concentrations of NECA
(10-8 M) that did not cause apparent cyclic AMP accumula-
tion if added alone (Figure 5a). Preincubation of CF/T43
cells with increasing concentrations of aminophylline or
IBMX resulted in a concentration-dependent inhibition of
the formation of cyclic AMP in response to 30 fM NECA
plus 10 1M forskolin. The IC50 values for aminophylline and
IBMX were 35 ^4M and 72 JM, respectively (Figure 5b). The
inhibitory effect of the methylxanthines was not observed in
CF/T43 cells stimulated with forskolin alone (not shown).
To test whether the CF/T43 cells selected for study
accurately reflected adenosine receptor activation in human
airway epithelium, the ability of NECA to stimulate the
formation of cyclic AMP in primary culture of human airway
epithelial cells from normal and CF patients, as well as in a
cell line (BEAS39) derived from a normal subject, was
examined. Incubation of the cells for 2 min with NECA
200 250 caused concentration-dependent increases in cyclic AMP
accumulation in each cell type studied (Figure 6). NECA, at
soprenaline stimu- a maximal stimulatory concentration, was similarly effica-
[Is. The cells were cious in stimulating cyclic AMP accumulation in normal and
trations of amino- CF cells, being 3-4 times more effective in the cell lines than
)prenaline (0) or in primary cells (Figure 6). The K0.5 values for NECA (in jaM)
Lge of the response were as follows: normal primary cells, 0.6 (n = 3); CF pri-
nean of triplicate mary cells, 3.0 (n = 2); BEAS39 cells, 3.0 (n = 2), and CF/
T43 cells, 1.1 (n = 5).
We also examined whether an A,-adenosine receptor cap-
able of inhibiting cyclic AMP accumulation was present on
CF/T43 cells. Combined addition of NECA and submaximal
concentrations of isoprenaline resulted in slightly (24% ± 11)
enhanced cyclic AMP accumulation over that observed with
isoprenaline alone. No significant inhibitory effect of CPA or
R-PIA on isoprenaline-stimulated cyclic AMP levels occurred
(not shown). These data suggest that Al-adenosine receptors
are not expressed on airway epithelial cells.
The effect of P2-purinoceptor agonists on the levels of
cyclic AMP in CF/T43 cells was also studied. Incubation of
the cells with either ADP, ATP or UTP (Figure 1), or with
ADPPS, 2-methylthio-ATP or ocp-methylene ATP (not
shown) did not result in increased cyclic AMP accumulation.
Neither ATP, adenosine-5'-0-3-thiotriphosphate (ATPyS) or
UTP (each at 100 gM) caused changes in a 1 to 10 min time
course of isoprenaline-stimulated cyclic AMP accumulation
10-3
on of cyclic AMP
belled and prein-
2. The cells were
rations of NECA
4 (0), 20 gM (0),
ults are plotted as
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Figure 5 Potentiation of NECA-stimulated cyclic AMP accumula-
tion by forskolin. CF/T43 cells were labelled and preincubated as
indicated in the legend of Figure 2. (a) The cells were challenged for
5 min with the indicated concentrations of NECA with (0) or
without (0) the concurrent addition of 10 1M of forskolin. (b) The
cells were preincubated for 10 min with the indicated concentrations
of aminophylline (0) or IBMX (0) and challenged for 5 min with
30 jAM NECA plus 10pM of forskolin. Results are plotted as the
percentage conversion of [3H]-ATP to [3H]-cyclic AMP and they are
the mean of triplicate determinations. For abbreviations, see text.












































Figure 6 Effect of NECA on [3H]-cyclic AMP accumulation in
human airway epithelial cells. Primary tissue from human airway
epithelia excised from control subjects (a) or cystic fibrosis (CF)
patients (b) and BEAS39 (c) and CF/T43 (d) cells were labelled with
[3H]-adenine as indicated in Methods. Cells were preincubated for
10 min with 200 AM papaverine and then challenged with the indicat-
ed concentration of NECA for 2 min. The results are plotted as the
percent conversion of [3H]-ATP to [3H]-cyclic AMP and are the mean
of triplicate determinations. For abbreviations, see text.
(isoprenaline = 10 AM, data not shown). These data suggest
that cyclic AMP levels are not regulated by P2-purinoceptors
in CF/T43 cells.
We have previously shown that the P2-purinoceptor agon-
ist, ATP, induces a rapid increase in [Ca2+], (net increase:
739 ± 171 nM) in human nasal epithelium (Mason et al.,
1991). To determine whether airway epithelial cells possess a
PI-receptor subtype linked to elevation of [Ca2+]i, we studied
the effect of the adenosine analogues on fura-2-loaded human
nasal epithelial cells. In contrast to the effect of ATP, addi-
tion of 100 gM adenosine or NECA caused delayed (1-2 min
after addition) and negligible (10-20 nM) changes in [Ca2+]i.
Addition of CPA and R-PIA initiated no change in [Ca2]j
(data not shown).
In bioelectric studies of human nasal epithelium, we have
recently demonstrated that extracellular adenine nucleotides
stimulate Cl- secretion, as measured by changes in I4, in
amiloride-pretreated cells (Mason et al., 1991). Pretreatment
of monolayers with amiloride (100f1M) effectively removes
the Na' absorptive component of 4,, so that the residual I4,
reflects a basal Cl- secretory activity (Boucher et al., 1986;
Willumsen et al., 1989). The effect of adenosine receptor
agonists on IA, in amiloride pretreated polarized human nasal
epithelium is illustrated in Figure 7. The observed rank order
of potency of Cl- secretory stimulation for the adenosine
analogues was NECA> adenosine> R-PIA > CPA when
applied to either the apical (Figure 7a) or basolateral (Figure
7b) surface.
Representative tracings of I4, in normal and CF primary
nasal epithelium are shown in Figure 8. Exposure of amilo-
ride pretreated normal nasal epithelium to a NECA concen-
tration causing maximal cyclic AMP accumulation resulted
in the complete lack of response to a second addition of
NECA and in a markedly diminished response to isoprena-
line (Figure 8a). In contrast, the 4,, response to ATP follow-
ing NECA and isoprenaline was in the range reported for
untreated tissues (Mason et al., 1991). Amiloride pretreated
CF tissue showed no C1- secretory response to NECA or
isoprenaline, but a large response was observed to ATP
(Figure 8b).
Additivity between PI-purinoceptor and P-adrenoceptor
agonists and between PI and P2-purinoceptor agonists for
stimulation of Cl- secretion was tested in normal tissues
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Figure 7 Effect of adenosine analogues on IS, changes in human
airway epithelium. Confluent monolayers of primary human nasal
epithelium were pretreated with amiloride as indicated in Methods
followed by apical (a) or basolateral (b) addition of NECA (U),
adenosine (0), R-PIA (0) or CPA (A). The results are based on the
agonist-stimulated peak change in ISC and are plotted as percentage
change in IS. The data represent the mean of 3-12 determinations
from tissues obtained from 3-10 different normal donors. ISC values
of amiloride pretreated unstimulated cells were 15.5 ± 4.6 pA cm-2 in
(a) and 15.7 ± 6.1 LA cm-2 in (b). For abbreviations, see text.
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Figure 8 Representative bioelectric tracings of 4,, in human airway
epithelium. Primary cultures of human nasal epithelium from a
normal (a) or a cystic fibrosis (b) donor were pretreated with
amiloride as indicated in Methods and stimulated with consecutive
(apical) addition of 100 pM NECA, 10 AM isoprenaline (Iso) and
100 9AM ATP. Control post-amiloride I, were 24 ftA cm-2 in (a) and
38 gA cm2 in (b). The data are representative of experiments per-
formed with tissue from at least four different donors.
individual membrane potentials and resistances were studied
during cellular impalement with conventional microelec-
trodes. As shown in Figure 10, upper trace, luminal applica-
tion of NECA (100 AM) to amiloride pretreated human nasal
epithelium cultures induced an increase in transepithelial
potential difference (Vt) and a decrease in transepithelial
resistance (R.), indicated by a decrease in the amplitude of
the current-induced voltage deflection. These changes indicate
an increase in the equivalent short circuit current. As shown
in the lower trace, NECA application induced an abrupt
depolarization of the apical membrane potential (Va). Note
also that the apical membrane voltage response to the cur-
rent pulses decreased to a relatively greater degree than in the
Vt tracing, indicating a decrease in the fractional resistance of
the apical membrane. Like the previous Ussing chamber data
(see Figure 8), NECA stimulated a significant increase in Cl-
secretion (4q) (Table 2). During the response, the cellular
changes were (1) depolarization of Va and (2) a decrease in
fRa, which coupled with a decrease in Rt, indicated a
decrease in the resistance (i.e., increased conductance) of the
apical membrane. Thus, the Cl- secretory response resulting
from NECA application was associated with the induction of
a depolarizing conductance in the apical membrane, which is
























Figure 9 I4, changes in human airway epithelium stimulated by
combined addition of NECA, isoprenaline and ATP. Human nasal
epithelium from normal donors were treated with amiloride as
indicated in Methods. (a) The cells was challenged with 100 9M
NECA (hatched columns) either before (left) or after (right) the
addition of 109M isoprenaline (open columns). (b) The cells were
stimulated by 100 AM ATP alone (left) or after the addition of
100 AM NECA (right). In each set of experiments, the addition of the
second agonist followed stabilization of the response to the first one.
All additions were on the apical surface of the monolayer. For
abbreviations, see text.
with sequential additions of NECA and isoprenaline, the I,,
response to the second agonist was substantially reduced,
irrespective of the order of the additions (Figure 9a). These
results suggest that these agonists stimulated Cl- transport at
least in part through a common mechanism. In contrast, the
ATP response following NECA was not significantly different
from the response to ATP alone suggesting additivity of
these agents (Figure 9b).
Cyclic AMP-dependent activation of Cl- secretion in
human airway epithelium, e.g. in response to isoprenaline,
results from a primary activation of an apical membrane Cl-
conductance (Widdicombe et al., 1985; Boucher et al., 1988).
To test whether activation of A2-receptors with NECA
induces Cl- secretion by a similar mode, changes in the
In this study we have expanded our previous investigations
of the effect of adenosine and adenine nucleotides in human
airway epithelial cells. Previously, we have shown that extra-
cellular ATP stimulates the formation of inositol phosphates
(Brown et al., 1991), raises [Ca2+]j, and increases the rate of
Cl- transport (Mason et al., 1991) in human nasal epithe-
lium. Here, we demonstrate that extracellular adenosine
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Figure 10 Representative microelectrode tracings of transepithelial
and apical membrane responses to NECA. Amiloride pretreated
human nasal epithelium was challenged with 1009AM NECA added
to the apical bath. Upper trace, transepithelial potential difference
(Vt). Lower trace, apical membrane potential (Va). Voltage deflect-
ions are in response to constant current pulses (-40 JLA cm-2).
780 E.R. LAZAROWSKI et al.
Table 2 Effect of 5-N-ethyl-carboxamidoadenosine (NECA) on Cl- secretion in amiloride pretreated nasal epithelial cell cultures
Transepithelial parameters
vt R. 'eq
(mV) (fl.cm2) (iuA cm-2)
A Basal -2.9 ± 0.9












- 30.2 ± 3






1.9 -33.1 ±4.4 a
.3 -30.6±4.4 0
.6 2.5 ± 1.7 -0
Basal and NECA (100 gM, luminal application) data values were measured during a continuous cellular impalement of each primary
culture with microelectrodes as indicated in Methods. The values represent the means ( ± s.e.mean) from four experiments. All NECA
values were recorded simultaneously with the maximal change in Iq. Amiloride (100 tM) was added to the luminal bath prior to
experiment. *P< 0.05 (paired t test). Abbreviations: Vo, Va and Vb, transepithelial, apical and basolateral membrane potential
differences, respectively; R., transepithelial resistance; Ieq equivalent short-circuit current; and fRa, fractional resistance of the apical
membrane.
airway epithelium, and that this effect appears to be mediated
by a cell surface receptor that responds to adenosine but not
to adenine nucleotides.
The effect of adenosine on cyclic AMP suggests the
existence of a stimulatory A2-adenosine receptor on airway
epithelium. Most notably, the A2-adenosine receptor agonist,
NECA, is the most potent and effective agonist at this recep-
tor. The order of potency of the adenosine analogues is
consistent with that observed in other tissues for stimulatory
A2-adenosine receptors (Van Calker, 1979; Londos et al.,
1980; Daly, 1982; Stone, 1990). The potency of NECA for
stimulation of cyclic AMP accumulation in epithelial cells
was lower than that reported for other tissues, e.g. rat liver
(Londos, 1980), and rat brain (Daly et al., 1983). However,
Daly (1982) has pointed out that the apparent potencies of
adenosine analogues show considerable range in different
tissues and the K0.5 values of NECA observed with primary
tissue and cell lines from human airway epithelium are within
this range.
The phenomenon of homologous desensitization is known
to occur following the activation of receptors coupled in a
stimulatory fashion to the enzyme adenylyl cyclase, e.g. P-
adrenoceptors (Harden, 1983; Sibley & Lefkowitz, 1985).
Previous studies in NG108-15 neuroblastoma-glioma hybrid
cells (Kenimer & Nirenberg, 1981), rat normal kidney (RNK)
fibroblasts (Newman & Levitzki, 1983) and DDT, MF-2
smooth muscle cells (Ramkumar et al., 1991) have shown
that the A2-receptor undergoes homologous desensitization
during exposure of cells to adenosine analogues. Consistent
with these reports, we have shown (Figure 2) that NECA-
treated CF/T43 cells became refractory to further stimulation
with the adenosine analogue but not with the P-receptor
agonist isoprenaline.
It is widely recognized that membrane-bound adenosine
receptors are competitively antagonized by methylxanthines
(Sattin & Rall, 1970; Fredholm, 1980; Daly et al., 1983;
Parsons & Stiles, 1985). As shown in Figures 3-5, the effect
of NECA on cyclic AMP accumulation in CF/T43 cells was
inhibited by IBMX and aminophylline and this effect was
specific for adenosine and its analogues.
Recently, it has been reported that adenosine stimulatory
receptors can co-exist in the same cell type with those coupl-
ed to inhibition of adenylate cyclase (Ramkumar et al.,
1990). However, our results show that A,-adenosine receptor
agonists R-PIA or CPA did not inhibit the effect of isopren-
aline on cyclic AMP accumulation and potentiating inter-
actions rather than inhibitory ones were observed by the
adenosine analogues on forskolin-stimulated CF/T43 cells
(Figure 5). The later observation supports the premise that
the action of adenosine is mediated through G,.
A recent report showed that adenosine stimulates phos-
pholipase C and Ca2" mobilization in RBL-2H3 cells with a
rank order of potency of agonists characteristic of an A2-
adenosine receptor (Ali et al., 1990). However, there was only
a negligible increase in [Ca2+], in NECA or adenosine-stimu-
lated human airway epithelial cells. Furthermore, we have
shown recently that adenosine does not stimulate inositol
phosphate accumulation in CF/T43 cells (Brown et al., 1991).
While adenylate cyclase is likely to be the earliest effector
of A2-adenosine receptor activation, the spectrum of distal
targets of this pathway in human airway epithelium has not
been fully identified. There have been previous reports that
adenosine-stimulated cyclic AMP accumulation and cyclic
AMP-dependent protein kinase in epithelial cells is associated
with increased Cl- secretion (Spinowitz & Sadunaitzki, 1979;
Dobbins et al., 1984; Pratt et al., 1986; Barrett et al., 1990).
Similarly, cyclic AMP plays an important role in regulating
Cl- transport in human airway epithelium. Evidence for this
notion comes from studies showing that isoprenaline and
other agents that increase cyclic AMP levels as well as cyclic
AMP-dependent protein kinase activate Cl- transport or
channels in normal human airway epithelia but not in CF
cells (Frizzel et al., 1986; Welch et al., 1986; Schoumacher et
al., 1987; Li et al., 1988; Boucher et al., 1988; 1989). From
these studies, we might expect adenosine and its analogues to
activate Cl- transport in normal epithelium but not in cells
from CF patients. Importantly, the direction of stimulated
Cl- transport, absorption versus secretion, is only known for
amiloride pretreated human nasal epithelia. In this condition
adenosine would be expected to induce an increase in secre-
tion.
The data presented here confirm these predictions. Indeed,
activation of Cl- secretion by adenosine (or analogues)
primarily reflects its actions on raising cyclic AMP levels as
indicated by the following data: (1) adenosine analogues
showed the same order of potency for stimulating Cl- secre-
tion and cyclic AMP accumulation; (2) NECA-stimulated
Cl- secretion and cyclic AMP accumulation occurred with
similar concentration-dependence; (3) analysis of the micro-
electrode data indicate that NECA, like isoprenaline, initiates
Cl- secretion via an action on the apical membrane Cl1
conductance, a conductance previously shown to be regulated
by cyclic AMP-dependent mechanisms; and (4) NECA failed
to induce Cl- secretion in cells obatined from patients with a
genetic inability to activate a Cl- conductance in response to
cyclic AMP, i.e., CF patients.
Data from studies of other cell systems indicate that
regulatory mechanisms in addition to cyclic AMP might
activate Cl- secretion subsequent to adenosine stimulation of
airway epithelial cells. Recently, it has been shown that
transepithelial Cl- secretion can be stimulated by Ca2` iono-
phores and by agonists that increase [Ca2+]i and the forma-
tion of inositol phosphates (Boucher et al., 1989; Mason et
al., 1991; Brown et al., 1991). Furthermore, adenosine-stimu-
lated Cl- secretion in CDD cells was associated with in-
creased inositol phosphate formation (Schwiebert et al.,
1990). However, as discussed above with reference to the
absence of changes in [Ca2+] in response to adenosine, this is
not the case in human airway epithelium.
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both normal and CF human airway epithelial cells express an
A2-type adenosine receptor that stimulates cyclic AMP
accumulation. This receptor is located functionally on both
the apical and basolateral surface of polarized airway
epithelia. The A2-receptor appears coupled via adenylate cyc-
lase activation to regulating the rate of Cl- secretion in
normal airway epithelium. Like the P-adrenoceptor, the
stimulatory adenosine receptor is functionally uncoupled
from stimulating C1- secretion in CF airway epithelial cells
due to a defect in a distal effector element, probably the CF
protein itself, and not due to abnormality in A2-receptor or
its coupling to adenylate cyclase.
This work was supported by the National Institute of Health grant
HL34322 and the Cystic Fibrosis Foundation grant R025.
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